Life science technologies, is a field often defined by high potential and equally high complexity. For investors, these include long development timelines, regulatory uncertainty, and the difficulty of assessing scientific risk. For startups, the hurdles are just as real, securing early funding, building credibility with non-specialist investors, navigating regulation, and bridging the gap between promising research and a viable market. Join us as we navigate the opportunities and underlying bases suronding this industry through the roles of both those that build these new technologies and those that invest in them.
